Cargando…
Somatic EPAS1 Variants in Pheochromocytoma and Paraganglioma in Patients With Sickle Cell Disease
CONTEXT: Somatic EPAS1 variants account for 5% to 8% of all pheochromocytoma and paragangliomas (PPGL) but are detected in over 90% of PPGL in patients with congenital cyanotic heart disease, where hypoxemia may select for EPAS1 gain-of-function variants. Sickle cell disease (SCD) is an inherited he...
Autores principales: | White, Gemma, Nonaka, Daisuke, Chung, Teng-Teng, Oakey, Rebecca J, Izatt, Louise |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10655516/ https://www.ncbi.nlm.nih.gov/pubmed/37285480 http://dx.doi.org/10.1210/clinem/dgad311 |
Ejemplares similares
-
Using Multimodal Functional Imaging in the Management of SDHx-Related Pheochromocytoma and Paraganglioma
por: White, Gemma, et al.
Publicado: (2021) -
Somatic mosaicism of EPAS1 mutations in the syndrome of paraganglioma and somatostatinoma associated with polycythemia
por: Yang, Chunzhang, et al.
Publicado: (2015) -
SUN-344 SDHB Immunostaining: Still an Indispensable Tool in Characterising Pheochromocytoma and Paraganglioma
por: Velusamy, Anand, et al.
Publicado: (2019) -
Whole exome sequencing identifies somatic ATRX mutations in pheochromocytomas and paragangliomas
por: Fishbein, Lauren, et al.
Publicado: (2015) -
Pheochromocytomas and secreting paragangliomas
por: Plouin, Pierre-François, et al.
Publicado: (2006)